$CHRS

$1.19▲ +11.2% YTD

4 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History

CP $1.19▲ +11.2%Oct 28, 2026 · ThinkSabio Blog

$CHRS - Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development…

News

CHRS ▲ +2.0% - Coherus Oncology, Inc.

CP $1.02▲ +2.0%Oct 27, 2026 · ThinkSabio Blog

$CHRS - Coherus to Participate in Upcoming Investor Conferences…

News

CHRS ▼ -1.9% - Coherus Oncology, Inc.

CP $1.05▲ -1.9%Oct 14, 2026 · ThinkSabio Blog

$CHRS - Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026…

SEC 13D/G

$CHRS SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified

$1.46▲ 6.57%Jul 27, 2026 · ThinkSabio Blog

$CHRS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CHRS : $1.46 Sector: Healthcare | YTD: 🔼+ 6.57% The SEC disclos…